Regulatory effects of herbal cake-partitioned moxibustion on the expressions of IL-17, IL-23 and their mRNAs in the colon of rats with Crohn’s disease

被引：0

作者：

Weng Z.-J. ^{[1
]}

Wu L.-Y. ^{[2
]}

Lü T.-T. ^{[1
]}

Zhang F. ^{[1
]}

Xie H.-R. ^{[1
]}

Sun T.-A. ^{[1
]}

Liu H.-R. ^{[1
]}

Wu H.-G. ^{[1
]}

机构：

[1] Shanghai Research Institute of Acupuncture and Meridian, Shanghai

[2] Shanghai Qigong Research Institute, Shanghai

来源：

Journal of Acupuncture and Tuina Science | 2016年 / 14卷 / 3期

关键词：

Crohn Disease; Indirect Moxibustion; Interleukin-17; Interleukin-23; Moxibustion Therapy; Point; Qihai (CV 6); Rats; Tianshu (ST 25);

D O I：

10.1007/s11726-016-0917-3

中图分类号：

学科分类号：

摘要：

Objective: To observe the regulatory effects of herbal cake-partitioned moxibustion on Crohn's disease (CD) rat’s colon inflammatory cytokine interleukin-17 (IL-17), IL-23 and their mRNAs, and to investigate the action mechanism of moxibustion in treating CD. Methods: Forty SPF grade Sprague-Dauley (SD) male rats were randomly divided into a normal group, a model group, an herbal cake-partitioned moxibustion group and a Western medicine group, with 10 rats in each group. Except the normal group, rats in the other three groups were used to make CD model by giving an enema in colon with Trinitro-benzene-sulfonic acid (TNBS). When the models were successful made, rats in the model group had no therapeutic intervention; rats in the herbal cake-partitioned moxibustion group were subjected to herbal cake-partitioned moxibustion treatment at bilateral Tianshu (ST 25) plus Qihai (CV 6); and rats in the Western medicine group were given oral Mesalazine. After treatment, the histopathological changes and inflammatory cytokines IL-17, IL-23 and their mRNAs expressions were observed in descending colon by hematoxylin-eosin (HE) staining, immunohistochemistry (IHC) and real-time polymerase chain reaction (RT-PCR) methods. Results: Colon tissues of TNBS enema rat models showed cracks-like ulcers accompanied by mucous layer inflammation, granulomas, and inflammatory cytokines IL-17, IL-23 and their mRNAs expressions were all higher than those in the normal group (P<0.01); after intervention, colon tissue cracks-like ulcers and inflammation degree reduced, inflammatory cytokines IL-17, IL-23 and their mRNAs expressions were all significantly decreased (P<0.01) in the herbal cake-partitioned moxibustion group and the Western medicine group. Conclusion: Herbal cake-partitioned moxibustion may improve colon tissue ulcers and relieve intestinal inflammation by down-regulation of IL-17, IL-23 and their mRNAs expressions in CD model rats’ colonic mucosa. © 2016, Shanghai Research Institute of Acupuncture and Meridian and Springer-Verlag Berlin Heidelberg.

引用

页码：156 / 163

页数：7

共 24 条

[1]

Cosnes J., Gower-Rousseau C., Seksik P., Cortot A., Epidemiology and natural history of inflammatory bowel diseases, Gastroenterology, 140, 6, pp. 1785-1794, (2011)

[2]

Hong J., Zhang C.H., Ma X.P., Pathogenesis of inflammatory bowel disease and the action mechanism of moxibustion, J Acupunct Tuina Sci, 10, 3, pp. 174-180, (2012)

[3]

Su J.W., Ma J.J., Zhang H.J., Use of antibiotics in patients with Crohn’s disease: a systematic review and meta-analysis, J Dig Dis, 16, 2, pp. 58-66, (2015)

[4]

Shi Y., Bao C.H., Wu H.G., Chen W.F., Qin X.D., Zhang R., Wu L.Y., Effects of herbs-partitioned moxibustion on the expression of intestinal mucosa TNF-a, TNFR1, TNFR2 and apoptosis of intestinal epithelial cells in Crohn’s disease patients, Shanghai Zhongyiyao Zazhi, 45, 1, pp. 46-50, (2011)

[5]

Bao C.H., Shi Y., Ma X.P., Li G., Liu H.R., Wu L.Y., Wu H.G., Pathogenesis of Crohn disease, advances in its acupuncture-moxibustion treatment and thinking, Shanghai Zhenjiu Zazhi, 29, 11, pp. 681-686, (2010)

[6]

Zhang X., Hu J., Suo L., Yang Z., Xu T., Zhang Y., IL-17 and IL-23 expression as a predictor of response to infliximab treatment in Crohn’s disease, Zhonghua Neike Zazhi, 54, 11, pp. 940-944, (2015)

[7]

Bank S., Andersen P.S., Burisch J., Pedersen N., Roug S., Galsgaard J., Ydegaard Turino S., Brodersen J.B., Rashid S., Kaiser Rasmussen B., Avlund S., Bastholm Olesen T., Hoffmann H.J., Andersen Nexo B., Sode J., Vogel U., Andersen V., Polymorphisms in the toll-like receptor and the IL-23/IL-17 pathways were associated with susceptibility to inflammatory bowel disease in a Danish cohort, PLoS One, 10, 12, (2015)

[8]

Catana C.S., Berindan Neagoe I., Cozma V., Magdas C., Tabaran F., Dumitrascu D.L., Contribution of the IL-17/IL-23 axis to the pathogenesis of inflammatory bowel disease, World J Gastroenterol, 21, 19, pp. 5823-5830, (2015)

[9]

Kolls J.K., Linden A., Interleukin-17 family members and inflammation, Immunity, 21, 4, pp. 467-476, (2004)

[10]

Berns M., Hommes D.W., Anti-TNF-a therapies for the treatment of Crohn’s disease: the past, present and future, Expert Opin Investig Drugs, 25, 2, pp. 129-143, (2016)

← 1 2 3 →